Treatment of rats with 1,25,28-trihydroxyvitamin D2 caused significant
up-regulation in kidney vitamin D receptor in the absence of hypercal
cemia. This result suggests that this relatively non-calcemic analogue
(and possibly other analogues) of vitamin D may be used in stimulatin
g vitamin D-regulated genetic events not associated with stimulation o
f active calcium transport in vivo.